A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3,...

25
A. Kittawornrat 1 , J. Prickett 1 , C. Wang 1,2 , C. Olsen 1 , C. Irwin 1 , Y. Panyasing 1 , A. Ballagi 3 , A . Rice 3 , R. Main 1 , C. Rademacher 4 , M. Hoogland 4 , J. Lowe 5 , J. Zimmerman 1 1 Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 2 Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA 3 IDEXX Laboratories, Inc., Westbrook, ME 4 Murphy-Brown LLC, Ames, IA 5 Carthage Veterinary Service, Ltd., Carthage IL

Transcript of A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3,...

Page 1: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

A. Kittawornrat1, J. Prickett1, C. Wang1,2, C. Olsen1, C. Irwin1, Y. Panyasing1, A. Ballagi3, A. Rice3, R. Main1, C. Rademacher4, M. Hoogland4, J. Lowe5, J. Zimmerman1

1Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 2Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA 3IDEXX Laboratories, Inc., Westbrook, ME4Murphy-Brown LLC, Ames, IA5Carthage Veterinary Service, Ltd., Carthage IL

Page 2: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

In human diagnostic medicine• 1909. “The agglutinating properties of

several body fluids during Malta Fever.” Pollaci and Ceralo

• 1986. Oral fluid antibodies used to detect HIV infection. J Clin Microbiol 24(5): 873

• Lots of research in humans (1909-2010)

• Primary focus on antibody detection• Widely used in surveillance

Page 3: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

BOARS: Confirm negative PRRS status of individual “seed stock” pigs

GILTS: Confirm PRRS status before entering breeding herds, preferably at the beginning and end of quarantines

SOWS and PIGLETS: Monitor vaccine effectiveness or confirm PRRS status

Boars

Gilts

Sows

Piglets

Simplified sampling would allow more frequent testing and provide more exact epidemiological information

Page 4: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

Pictures courtesy of Dr. John Prickett

Page 5: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.
Page 6: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

1. Optimize antibody isotypes

2. Optimize incubation period

3. Optimize sample dilution

4. Interactions (isotype x sample

dilution x sample volume)

5. Optimize conjugate dilution

Page 7: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

Conclusion from previous results

Page 8: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

Serum antibody assays (IDEXX PRRS X3 can be optimized to detect antibodies in oral fluid by

- IgGFC isotype (IgM, IgA, IgG can be detected)

- 250 μl sample volume- 16 hour incubation- 1:2 sample dilution- Other conjugate

Page 9: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

Wean-to-finish barns (1100 pigs)10 sites x 6 pens per site x sampling each 2 weeks. n = 600 total samples

• 10 barns: 1,100 head wean-finish- 1 oral fluid sample / pen; 6 pens /barn- Samples collected every 2 weeks from

placement to close-out (10 sample points)

- 600 oral fluid samples (PCR, ELISA)

Page 10: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

Page 11: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Avg. S/P = 0.30 Pos. = 23.3%

Avg. S/P = 0.04Pos. = 3.3%

Avg. S/P = 0.72Pos. = 53.3%

Avg. S/P = 0.34 Pos. = 30.0%

5 serum samples per pen (n = 30) at week 0

Page 12: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 13: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 14: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 15: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 16: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 17: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 18: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 19: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Page 20: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

    WEEK POST PLACEMENTBarn Pen 0 2 4 6 8 10 12 14 16 18

5 1 2.47 0.69 0.18 0.00 -0.03 0.00 0.01 P 2.11 1.13 1.68

2 4.66 0.98 0.18 0.12 0.05 -0.01 0.01 P 2.01 2.66 0.96

3 3.38 0.70 0.14 0.03 -0.03 -0.04 0.13 P 3.12 2.75 0.82

4 NS 1.28 0.14 0.18 0.03 0.01 0.01 P 2.73 2.48 0.98

5 1.25 1.87 0.27 0.12 -0.01 -0.03 -0.03 P 2.08 3.27 2.11 6 2.73 0.96 0.07 0.02 0.01 -0.03 -0.01 2.29 1.38 1.136 1 0.83 1.29 0.00 -0.02 -0.02 -0.04 2.29 2.46 1.98 1.79

2 0.04 0.51 -0.02 -0.02 0.14 -0.02 2.41 P 2.96 2.31 1.40 3 0.00 1.13 -0.04 -0.04 -0.04 -0.04 2.69 2.76 2.19 0.47

4 0.08 0.62 0.00 -0.03 -0.04 -0.03 2.93 P 3.05 2.12 0.89

5 0.00 0.79 -0.02 -0.01 -0.02 0.03 -0.02 2.18 P 1.72 1.46 6 -0.01 0.04 0.03 0.06 0.01 0.19 2.27 2.99 1.31 0.379 1 4.15 1.72 0.21 0.17 0.26 0.06 -0.02 0.01 0.02 3.20 2 4.27 1.79 0.34 0.19 0.07 -0.02 0.02 0.00 0.30 1.28 3 4.41 1.76 0.29 -0.02 0.08 0.02 0.00 0.00 -0.03 3.12 4 3.29 1.59 0.27 0.10 0.05 -0.02 0.03 -0.01 0.02 2.49 5 4.02 1.43 0.51 0.05 0.00 0.01 -0.01 0.04 0.02 3.28

6 4.01 0.91 0.83 0.38 0.13 0.03 0.06 0.02 0.01 2.19 P

10 1 -0.03 0.26 0.21 0.49 P 1.62 1.65 2.66 1.60 2.10 0.89

2 3.65 0.75 0.11 P 1.46 P 1.00 1.24 3.27 0.93 2.26 1.92

3 3.79 0.26 0.48 P 2.03 1.17 2.50 2.74 2.21 0.56 1.31

4 4.39 0.55 0.02 0.24 P 2.42 P 2.27 2.87 1.94 2.23 1.45 5 3.69 0.06 0.01 0.56 2.11 1.72 3.21 2.31 1.79 3.29

6 3.71 0.08 0.09 0.00 P 3.16 2.13 3.28 1.25 1.44 0.48

< 0.40≥ 0.40≥ 0.40 P

< 0.40 P

NS P

Avg. S/P = 0.93Pos. = 93.3%

Avg. S/P = 0.78 Pos. = 70.0%

Avg. S/P = 1.40Pos. = 96.7%

Avg. S/P = 1.06Pos. = 86.7%

30 serum samples at week 18

Page 21: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

• Source of positive samples– Experimental samples– Field samples

– For any pen, all samples after the first PCR positive result were considered positive

• Source of negative samples– Experimental (DPI 0)– Field samples from expected PRRSV

negative herds submitted to ISU VDL

Page 22: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

NEGATIVE SAMPLESExperimental = 84Field neg (ISU VDL) = 283TOTAL = 367

POSITIVE SAMPLESExperimental = 251Field = 241TOTAL = 492

Page 23: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.
Page 24: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

• Kinetics of anti-PRRSV antibodies in oral fluid is amenable to rapid detection of infection.

• The oral fluid ELISA could provide an efficient, cost-effective approach to PRRSV monitoring in commercial herds and surveillance in elimination programs.

Page 25: A. Kittawornrat 1, J. Prickett 1, C. Wang 1,2, C. Olsen 1, C. Irwin 1, Y. Panyasing 1, A. Ballagi 3, A. Rice 3, R. Main 1, C. Rademacher 4, M. Hoogland.

• IDEXX Laboratories, Inc.

• National Pork Board (Pork Checkoff funds)

• PRRS CAP, USDA NIFA award 2008-55620-1932

• Request reference standard samples contact to Dr. Zimmerman ([email protected])

• Request SOP contact to Dr. Johnson ([email protected])